SCHEMBL7517850

SCHEMBL7517850

CC(C)C(=O)Nc1nc2c(ncn2[C@H]2C[C@H](NC(c3ccccc3)(c3ccccc3)c3ccccc3)[C@@H](CO[Si](C)(C)C(C)(C)C)O2)c(=O)[nH]1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.54
TAS1R3 Q7RTX0 2/20 0.42
TAS1R1 Q7RTX1 2/20 0.42
TYMP P19971 1/20 0.41
POLA1 P09884 1/20 0.39
POLB P06746 1/20 0.36
IMPDH2 P12268 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
TOP2A P11388 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HINT1 P49773 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
P2RY2 P41231 1/20 0.33
P2RY4 P51582 1/20 0.33
P2RY6 Q15077 1/20 0.33
NT5E P21589 1/20 0.33
HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17279179 1.00 KDM4E (0.54) KDM4ETAS1R3TAS1R1TYMPPOLA1
SCHEMBL16609224 0.92 KDM4E (0.56) KDM4ETAS1R3TAS1R1TYMPPOLA1
SCHEMBL6470562 0.89 KDM4E (0.62) KDM4ETAS1R3TAS1R1TYMPPOLA1
SCHEMBL17279165 0.89 KDM4E (0.62) KDM4ETAS1R3TAS1R1TYMPPOLA1
SCHEMBL8665070 0.89 KDM4E (0.62) KDM4ETAS1R3TAS1R1TYMPPOLA1
SCHEMBL16609168 0.87 KDM4E (0.52) KDM4ETAS1R3TAS1R1TYMPPOLA1
SCHEMBL19662703 0.85 KDM4E (0.61) KDM4ETAS1R3TAS1R1TYMPPOLA1
SCHEMBL18671304 0.85 KDM4E (0.61) KDM4ETAS1R3TAS1R1TYMPPOLA1
SCHEMBL3821420 0.85 KDM4E (0.61) KDM4ETAS1R3TAS1R1TYMPPOLA1
SCHEMBL3821424 0.85 KDM4E (0.61) KDM4ETAS1R3TAS1R1TYMPPOLA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882059-B1 SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDE N3-'P5'- PHOSPHORAMIDATES LYNX THERAPEUTICS INC (US) 2002-02-06 EP disclosed
EP-0882059-A1 SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDE N3-'P5'- PHOSPHORAMIDATES LYNX THERAPEUTICS, INC. (US) 1998-12-09 EP disclosed
WO-1997031009-A1 SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDE N3'→P5' PHOSPHORAMIDATES LYNX THERAPEUTICS, INC. (US) 1997-08-28 WO disclosed